AUM$9.1M
Expense Ratio0.45%
NAV$29.42
Holdings64
InceptionJan 14, 2021
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
$28.18$32.02
Avg Volume
—Dividend Yield
—Expense Ratio
0.45%AUM
$9.1MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 62.29% |
| Consumer Cyclical | 9.08% |
| Cash & Others | 7.95% |
| Technology | 6.81% |
| Communication Services | 5.77% |
| Financial Services | 5.61% |
| Industrials | 1.62% |
| Consumer Defensive | 0.87% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 66.86% |
| Other | 7.95% |
| Switzerland | 6.82% |
| United Kingdom | 5.84% |
| Ireland | 3.81% |
| Spain | 3.59% |
| Japan | 2.04% |
| Thailand | 1.12% |
| Taiwan (Province of China) | 0.94% |
| Sweden | 0.52% |
| Australia | 0.50% |
Fund Information
- Issuer
- NY Life Investments
- Category
- Healthcare
- Inception Date
- Jan 14, 2021
- Description
- The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the index, which was developed by IndexIQ LLC with Candriam Belgium S.A. acting as index consultant to IndexIQ. The index includes securities of large-, mid- and small-capitalization companies that trade in the U.S. and foreign markets, including emerging markets other than China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia and United Arab Emirates.
Similar ETFs
The NYLI Healthy Hearts ETF (HART) is an exchange-traded fund issued by NY Life Investments that launched on Jan 14, 2021. It currently manages $9.1M in assets under management. The fund charges an expense ratio of 0.45%. The fund holds 64 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 51.7% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | GOOGL | Alphabet Inc. Class A | 5.77% | 2,594 | $529K |
| 2 | AAPL | Apple Inc. | 5.61% | 2,218 | $514K |
| 3 | JNJ | Johnson & Johnson | 5.54% | 2,871 | $507K |
| 4 | AZN.L | AstraZeneca PLC | 5.29% | 3,082 | $484K |
| 5 | NOVN.SW | Novartis AG | 5.25% | 3,893 | $481K |
| 6 | PFE | Pfizer Inc. | 5.20% | 18,968 | $477K |
| 7 | UNH | UnitedHealth Group Incorporated | 4.90% | 1,476 | $449K |
| 8 | ABT | Abbott Laboratories | 4.80% | 3,336 | $440K |
| 9 | BSX | Boston Scientific Corporation | 4.77% | 4,233 | $437K |
| 10 | LLY | Eli Lilly and Company | 4.62% | 604 | $424K |
| 11 | MDT | Medtronic Plc | 3.81% | 3,751 | $349K |
| 12 | NOVOB.CO | Novo Nordisk A/S Class B | 3.60% | 6,454 | $330K |
| 13 | SAN | Sanofi SA | 3.59% | 3,307 | $329K |
| 14 | BMY | Bristol-Myers Squibb Company | 3.14% | 5,939 | $288K |
| 15 | NKE | NIKE Inc. Class B | 2.86% | 3,400 | $262K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — | ||
| 1W | — | — | ||
| 1M | — | — | ||
| 3M | — | — | ||
| 6M | — | — | ||
| YTD | — | — | ||
| 1Y | -2.97% | — | ||
| 3Y | +18.79% | — | ||
| 5Y | +21.00% | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
$32.02
Current Price
—
52-Week Low
$28.18
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | HART | Healthcare(223 ETFs) | Small Cap(308 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.45% | 0.60% | 0.57% |
| AUM | $9.1M | $1.24B | $11.82B |
| Dividend Yield | — | 2.75% | 2.76% |
| Avg Volume | — | 800.9K | 1.9M |
| Holdings | 64 | 171 | 480 |
| Performance | |||
| 1-Month Return | — | -4.57% | -6.05% |
| 6-Month Return | — | +4.90% | +3.72% |
| YTD Return | — | -1.70% | +1.40% |
| 1-Year Return | — | +15.18% | +19.12% |
Compare with Another ETF
Search for an ETF to compare with HART: